Annual ROE
-37.45%
-7.32%-24.29%
31 December 2023
Summary:
Celldex Therapeutics annual return on equity is currently -37.45%, with the most recent change of -7.32% (-24.29%) on 31 December 2023. During the last 3 years, it has risen by +1.96% (+4.97%). CLDX annual ROE is now -155.07% below its all-time high of 68.00%, reached on 30 April 1986.CLDX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-24.74%
+4.08%+14.16%
01 September 2024
Summary:
Celldex Therapeutics quarterly return on equity is currently -24.74%, with the most recent change of +4.08% (+14.16%) on 01 September 2024. Over the past year, it has increased by +16.84% (+40.50%). CLDX quarterly ROE is now -110.22% below its all-time high of 242.15%, reached on 30 September 2007.CLDX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.3% | +40.5% |
| 3 y3 years | +5.0% | +14.3% |
| 5 y5 years | +55.4% | +42.8% |
CLDX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -67.0% | +5.0% | -4.7% | +44.6% |
| 5 y | 5 years | -67.0% | +55.4% | -4.7% | +47.3% |
| alltime | all time | -155.1% | +98.7% | -110.2% | +99.9% |
Celldex Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -24.74%(-14.2%) |
| June 2024 | - | -28.82%(-16.7%) |
| Mar 2024 | - | -34.58%(-22.6%) |
| Dec 2023 | -37.45%(+24.3%) | -44.69%(+7.5%) |
| Sept 2023 | - | -41.58%(+18.9%) |
| June 2023 | - | -34.98%(+2.5%) |
| Mar 2023 | - | -34.14%(+12.7%) |
| Dec 2022 | -30.13%(+34.3%) | -30.29%(+12.3%) |
| Sept 2022 | - | -26.97%(-2.5%) |
| June 2022 | - | -27.66%(+17.1%) |
| Mar 2022 | - | -23.62%(-3.4%) |
| Dec 2021 | -22.43%(-43.1%) | -24.45%(-15.3%) |
| Sept 2021 | - | -28.85%(-7.9%) |
| June 2021 | - | -31.32%(-6.0%) |
| Mar 2021 | - | -33.32%(-4.6%) |
| Dec 2020 | -39.41%(-15.5%) | -34.94%(+8.1%) |
| Sept 2020 | - | -32.32%(-10.9%) |
| June 2020 | - | -36.29%(-21.3%) |
| Mar 2020 | - | -46.13%(-1.7%) |
| Dec 2019 | -46.66%(-44.4%) | -46.95%(+8.5%) |
| Sept 2019 | - | -43.27%(+14.2%) |
| June 2019 | - | -37.89%(-5.5%) |
| Mar 2019 | - | -40.10%(-60.2%) |
| Dec 2018 | -83.89%(+126.2%) | -100.70%(+17.0%) |
| Sept 2018 | - | -86.09%(-0.8%) |
| June 2018 | - | -86.79%(+4.9%) |
| Mar 2018 | - | -82.75%(+113.5%) |
| Dec 2017 | -37.08%(-19.9%) | -38.76%(-24.7%) |
| Sept 2017 | - | -51.44%(-1.3%) |
| June 2017 | - | -52.12%(-0.3%) |
| Mar 2017 | - | -52.29%(+3.1%) |
| Dec 2016 | -46.27%(-8.7%) | -50.71%(+3.9%) |
| Sept 2016 | - | -48.81%(+7.8%) |
| June 2016 | - | -45.29%(+9.4%) |
| Mar 2016 | - | -41.41%(+0.4%) |
| Dec 2015 | -50.70%(+14.1%) | -41.25%(-2.6%) |
| Sept 2015 | - | -42.36%(-0.5%) |
| June 2015 | - | -42.58%(-0.4%) |
| Mar 2015 | - | -42.77%(-3.8%) |
| Dec 2014 | -44.44%(+13.2%) | -44.46%(+4.5%) |
| Sept 2014 | - | -42.54%(-0.4%) |
| June 2014 | - | -42.69%(+3.4%) |
| Mar 2014 | - | -41.27%(-4.4%) |
| Dec 2013 | -39.25%(-45.4%) | -43.18%(-19.0%) |
| Sept 2013 | - | -53.31%(+2.2%) |
| June 2013 | - | -52.18%(-3.1%) |
| Mar 2013 | - | -53.87%(-16.5%) |
| Dec 2012 | -71.88%(+15.5%) | -64.55%(+3.9%) |
| Sept 2012 | - | -62.15%(+6.5%) |
| June 2012 | - | -58.35%(+0.4%) |
| Mar 2012 | - | -58.13%(-0.8%) |
| Dec 2011 | -62.23%(+1730.3%) | -58.57%(+355.4%) |
| Sept 2011 | - | -12.86%(+32.0%) |
| June 2011 | - | -9.74%(+4.2%) |
| Mar 2011 | - | -9.35%(+143.5%) |
| Dec 2010 | -3.40%(-95.7%) | -3.84%(-94.9%) |
| Sept 2010 | - | -75.67%(-14.7%) |
| June 2010 | - | -88.66%(-21.8%) |
| Mar 2010 | - | -113.42%(-34.3%) |
| Dec 2009 | -79.49%(-85.8%) | -172.69%(-37.9%) |
| Sept 2009 | - | -277.97%(+54.3%) |
| June 2009 | - | -180.11%(+21.3%) |
| Mar 2009 | - | -148.50%(-38.5%) |
| Dec 2008 | -558.77%(-80.9%) | -241.28%(-27.7%) |
| Sept 2008 | - | -333.63%(-44.7%) |
| June 2008 | - | -603.76%(-96.8%) |
| Mar 2008 | - | -18.67 K%(-8546.9%) |
| Dec 2007 | -2929.41%(+1793.0%) | 221.05%(-8.7%) |
| Sept 2007 | - | 242.15%(-131.7%) |
| June 2007 | - | -763.70%(+203.0%) |
| Mar 2007 | - | -252.07%(+74.5%) |
| Dec 2006 | -154.75%(+153.5%) | -144.45%(+34.2%) |
| Sept 2006 | - | -107.65%(+32.7%) |
| June 2006 | - | -81.12%(+26.7%) |
| Mar 2006 | - | -64.04%(+3.8%) |
| Dec 2005 | -61.04% | -61.68%(+16.2%) |
| Sept 2005 | - | -53.09%(+17.8%) |
| June 2005 | - | -45.05%(+16.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2005 | - | -38.67%(+19.1%) |
| Dec 2004 | -39.81%(-6.9%) | -32.48%(-5.4%) |
| Sept 2004 | - | -34.34%(+3.3%) |
| June 2004 | - | -33.23%(-4.1%) |
| Mar 2004 | - | -34.65%(-21.3%) |
| Dec 2003 | -42.76%(+18.4%) | -44.05%(+9.5%) |
| Sept 2003 | - | -40.24%(+20.4%) |
| June 2003 | - | -33.41%(-7.6%) |
| Mar 2003 | - | -36.16%(-2.1%) |
| Dec 2002 | -36.10%(-21.3%) | -36.95%(-16.6%) |
| Sept 2002 | - | -44.28%(-21.9%) |
| June 2002 | - | -56.72%(+5.1%) |
| Mar 2002 | - | -53.97%(+10.4%) |
| Dec 2001 | -45.87%(-25.5%) | -48.88%(-21.6%) |
| Sept 2001 | - | -62.38%(-0.5%) |
| June 2001 | - | -62.71%(-1.1%) |
| Mar 2001 | - | -63.43%(-10.4%) |
| Dec 2000 | -61.60%(-1.4%) | -70.78%(+43.2%) |
| Sept 2000 | - | -49.43%(-21.4%) |
| June 2000 | - | -62.89%(+2.3%) |
| Mar 2000 | - | -61.50%(-5.5%) |
| Dec 1999 | -62.46%(-84.9%) | -65.06%(+17.9%) |
| Sept 1999 | - | -55.19%(-84.4%) |
| June 1999 | - | -353.32%(-4.7%) |
| Mar 1999 | - | -370.81%(-11.4%) |
| Dec 1998 | -412.75%(+245.0%) | -418.42%(-16.6%) |
| Sept 1998 | - | -501.97%(+243.2%) |
| June 1998 | - | -146.28%(+12.2%) |
| Mar 1998 | - | -130.43%(+10.1%) |
| Dec 1997 | -119.63%(+75.0%) | -118.44%(+13.4%) |
| Sept 1997 | - | -104.48%(+75.0%) |
| June 1997 | - | -59.71%(-21.4%) |
| Mar 1997 | - | -76.01%(+3.2%) |
| Dec 1996 | -68.35%(+38.4%) | -73.65%(+15.3%) |
| Sept 1996 | - | -63.88%(-15.7%) |
| June 1996 | - | -75.76%(+31.5%) |
| Mar 1996 | - | -57.61%(-1.3%) |
| Dec 1995 | -49.40%(-0.6%) | -58.37%(-29.1%) |
| Sept 1995 | - | -82.35%(+19.4%) |
| June 1995 | - | -68.97%(+18.3%) |
| Mar 1995 | - | -58.29%(+18.3%) |
| Dec 1994 | -49.68%(+56.4%) | -49.28%(+20.0%) |
| Sept 1994 | - | -41.08%(+3.0%) |
| June 1994 | - | -39.89%(+4.6%) |
| Mar 1994 | - | -38.13%(-2.5%) |
| Dec 1993 | -31.77%(+92.4%) | -39.12%(+8.7%) |
| Sept 1993 | - | -35.98%(+34.0%) |
| June 1993 | - | -26.86%(+10.3%) |
| Mar 1993 | - | -24.35%(+40.3%) |
| Dec 1992 | -16.51%(-39.0%) | - |
| Oct 1992 | - | -17.36%(-4.5%) |
| July 1992 | - | -18.17%(-11.8%) |
| Apr 1992 | - | -20.59%(-0.9%) |
| Apr 1992 | -27.06%(-6.5%) | - |
| Jan 1992 | - | -20.77%(-21.6%) |
| Oct 1991 | - | -26.50%(+2.4%) |
| July 1991 | - | -25.87%(-12.3%) |
| Apr 1991 | -28.94%(+211.2%) | -29.51%(+53.2%) |
| Jan 1991 | - | -19.26%(+60.0%) |
| Oct 1990 | - | -12.04%(+0.6%) |
| July 1990 | - | -11.97%(+37.6%) |
| Apr 1990 | -9.30%(-25.2%) | -8.70%(-33.6%) |
| Jan 1990 | - | -13.11%(-35.2%) |
| Oct 1989 | - | -20.24%(+21.4%) |
| July 1989 | - | -16.67%(-3.0%) |
| Apr 1989 | -12.43%(+2.1%) | -17.19%(+6.6%) |
| Jan 1989 | - | -16.13%(+15.4%) |
| Oct 1988 | - | -13.98%(+18.2%) |
| July 1988 | - | -11.83%(-43.5%) |
| Apr 1988 | -12.18%(-39.9%) | -20.93%(+81.4%) |
| Jan 1988 | - | -11.54%(+20.0%) |
| Oct 1987 | - | -9.62%(+11.2%) |
| July 1987 | - | -8.65%(+12.5%) |
| Apr 1987 | -20.25%(-129.8%) | -7.69%(-105.7%) |
| Jan 1987 | - | 136.00%(-12.8%) |
| Oct 1986 | - | 156.00%(-7.1%) |
| July 1986 | - | 168.00%(0.0%) |
| Apr 1986 | 68.00% | 168.00% |
FAQ
- What is Celldex Therapeutics annual return on equity?
- What is the all time high annual ROE for Celldex Therapeutics?
- What is Celldex Therapeutics annual ROE year-on-year change?
- What is Celldex Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly ROE year-on-year change?
What is Celldex Therapeutics annual return on equity?
The current annual ROE of CLDX is -37.45%
What is the all time high annual ROE for Celldex Therapeutics?
Celldex Therapeutics all-time high annual return on equity is 68.00%
What is Celldex Therapeutics annual ROE year-on-year change?
Over the past year, CLDX annual return on equity has changed by -7.32% (-24.29%)
What is Celldex Therapeutics quarterly return on equity?
The current quarterly ROE of CLDX is -24.74%
What is the all time high quarterly ROE for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly return on equity is 242.15%
What is Celldex Therapeutics quarterly ROE year-on-year change?
Over the past year, CLDX quarterly return on equity has changed by +16.84% (+40.50%)